GLP-1 clinical trials in Rhode Island: 6 recruiting now

6 sites in 4 Rhode Island cities. Registry checked October 2, 2026.

Screening for a study can take weeks. The cheapest program today is Strut Health.

No insurance needed.

  1. Strut Health$149 a month, with auto-refillcompounded semaglutideCheck price →You pick Weight Loss, then a five-minute online visit
  2. Shed$199 a month30% off first month with code Shed10compounded semaglutideCheck price →A health form first, then you choose your plan

Weight-loss studies (2)

Weight-loss study of KAI-9531

Where: East Greenwich

What: Tests whether an investigational medicine from Kailera, KAI-9531, can help people lose weight.

Free to join

Who can join: Adults 18+ with obesity, BMI 35+.

Study record on ClinicalTrials.gov

Kailera Clinical Site, East Greenwich

Weight-loss study of cagrisema

Where: Cumberland

What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lose weight.

Free to join

Who can join: Adults 18+ with obesity, BMI 35+.

Study record on ClinicalTrials.gov

Clinical Res Collaborative, Cumberland

Other GLP-1 studies in Rhode Island (4)

Ulcerative colitis study of tirzepatide

Where: Providence

What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with ulcerative colitis calm gut inflammation.

Free to join

Who can join: Adults 18 to 70 with ulcerative colitis, BMI 27+.

Call the site: 401-421-8800Study record on ClinicalTrials.gov

University Gastroenterology, Providence. 401-421-8800

Crohn's disease study of tirzepatide

Where: Providence

What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with Crohn's disease calm gut inflammation.

Free to join

Who can join: Adults 18 to 70 with Crohn's disease, BMI 27+.

Call the site: 401-421-8800Study record on ClinicalTrials.gov

University Gastroenterology, Providence. 401-421-8800

Fatty liver disease (MASLD) study of retatrutide

Where: Providence

What: Tests whether a GLP-1, GIP and glucagon medicine from Lilly, retatrutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (MASLD), BMI 25+.

Study record on ClinicalTrials.gov

University Gastroenterology, Providence

Show 1 more study

Source: ClinicalTrials.gov, the federal registry, read October 2, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.

Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.